<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Dialogues Clin Neurosci</journal-id>
<journal-id journal-id-type="iso-abbrev">Dialogues Clin Neurosci</journal-id>
<journal-id journal-id-type="pmc">Dialogues Clin Neurosci</journal-id>
<journal-title-group>
<journal-title>Dialogues in Clinical Neuroscience</journal-title>
</journal-title-group>
<issn pub-type="ppub">1294-8322</issn>
<issn pub-type="epub">1958-5969</issn>
<publisher>
<publisher-name>Les Laboratoires Servier</publisher-name>
<publisher-loc>France</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">32699508</article-id>
<article-id pub-id-type="pmc">7365298</article-id>
<article-id pub-id-type="doi">10.31887/DCNS.2020.22.1/bcuthbert</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Brief Report</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>The role of RDoC in future classification of mental
disorders </article-title>
<trans-title-group xml:lang="es">
<trans-title>El papel de los Criterios de Dominio de Investigación en las futuras clasificaciones de los trastornos mentales</trans-title>
</trans-title-group>
<trans-title-group xml:lang="fr">
<trans-title>Rôle des Critères de domaines de recherche dans la future classification des troubles mentaux</trans-title>
</trans-title-group>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Cuthbert</surname>
<given-names>Bruce N.</given-names>
</name>
<degrees>PhD</degrees>
<aff>National Institute of Mental Health, Bethesda, Maryland, US</aff>
</contrib>
</contrib-group>
<author-notes>
<corresp id="COR1">Bruce N. Cuthbert, PhD, National Institute of Mental Health6001
Executive Blvd, Room 8151, MSC 9632, Bethesda, MD 20892-9632, US<label>*</label>
E-mail: <email>bcuthber@mail.nih.gov</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>3</month>
<year>2020</year>
</pub-date>
<!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' -->
<pub-date pub-type="ppub">
<month>3</month>
<year>2020</year>
</pub-date>
<volume>22</volume>
<issue>1</issue>
<fpage>81</fpage>
<lpage>85</lpage>
<permissions>
<copyright-statement>© 2019, AICHServier Group﻿Copyright © 2019 AICH Servier Group. All
rights reserved</copyright-statement>
<copyright-year>2020</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-nd/3.0/">
<license-p>This is an open-access article distributed under the terms of the Creative
Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-nd/3.0/">http://creativecommons.org/licenses/by-nc-nd/3.0/</ext-link>), which permits
unrestricted use, distribution, and reproduction in any medium, provided the
original work is properly cited.</license-p>
</license>
</permissions>
<abstract>
<p>The Research Domain Criteria (RDoC) project constitutes a translational framework for
psychopathology research, initiated by the National Institute of Mental Health in an
attempt to provide new avenues for research to circumvent problems emerging from the
use of symptom-based diagnostic categories in diagnosing disorders. The RDoC
alternative is a focus on psychopathology based on dimensions simultaneously defined
by observable behavior (including quantitative measures of cognitive or affective
behavior) and neurobiological measures. Key features of the RDoC framework include an
emphasis on functional dimensions that range from normal to abnormal, integration of
multiple measures in study designs (which can foster computational approaches), and
high priority on studies of neurodevelopment and environmental influences (and their
interaction) that can contribute to advances in understanding the etiology of
disorders throughout the lifespan. The paper highlights key implications for ways in
which RDoC can contribute to future ideas about classification, as well as some of
the considerations involved in translating basic behavioral and neuroscience data to
psychopathology. </p>
</abstract>
<trans-abstract xml:lang="es">
<p>El proyecto Research Domain Criteria (Criterios de Dominio de Investigación, CDI) constituye un marco traslacional para la investigación en psicopatología y fue iniciado por el Instituto Nacional de Salud Mental en un intento por proporcionar nuevas alternativas de investigación para sortear los problemas que surgen del uso de categorías diagnósticas basadas en síntomas para el diagnóstico de los trastornos mentales. La propuesta CDI se centra en la psicopatología basada en dimensiones, las cuales se definen simultáneamente por el comportamiento observable (incluyendo las mediciones cuantitativas del comportamiento cognitivo o afectivo) y las mediciones neurobiológicas. Las características clave de los CDI incluyen un énfasis en las dimensiones funcionales que van de lo normal a lo anormal, la integración de múltiples mediciones en los diseños de estudio (que pueden fomentar enfoques computacionales) y una alta prioridad en los estudios del neurodesarrollo y de las influencias ambientales (y de su interacción), todo lo cual puede contribuir a los avances en la comprensión de la etiología de los trastornos a lo largo de la vida. Este artículo destaca las consecuencias clave de las formas en que los CDI pueden contribuir a futuras ideas acerca de la clasificación, así como a algunas de las consideraciones involucradas en la traducción de datos básicos del comportamiento y de la neurociencia para la psicopatología.</p>
</trans-abstract>
<trans-abstract xml:lang="fr">
<p>Le National Institute of Mental Health a créé le projet des Critères de domaines de recherche (RDoC, Research Domain Criteria) comme cadre de recherche en psychopathologie, dans le but d’ouvrir les champs de recherche en contournant les problèmes issus des catégories diagnostiques basées sur les symptômes des maladies. Le RDoC est centré sur la psychopathologie et s’appuie sur un comportement observable (y compris des données quantitatives de comportement cognitif ou affectif) comme sur des données neurobiologiques. Structuré autour de caractéristiques essentielles, le RDoC valorise les dimensions fonctionnelles (de normales à anormales), les études de conceptions différentes (pouvant favoriser les méthodes numériques), et prioritairement les études de neurodéveloppement, les influences environnementales et leurs interactions qui peuvent améliorer la compréhension de l’étiologie des maladies au cours de la vie. Cet article souligne les principaux messages concernant les apports du RDoC aux nouvelles méthodes de classification, ainsi que certaines observations en lien avec la traduction des données fondamentales neuroscientifiques et comportementales en psychopathologie.</p>
</trans-abstract>
<kwd-group>
<kwd>
<italic>psychiatric diagnosis</italic>
</kwd>
<kwd>
<italic>psychiatric nosology</italic>
</kwd>
<kwd>
<italic>Research Domain Criteria</italic>
</kwd>
<kwd>
<italic>RDoC</italic>
</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec>
<title>Introduction </title>
<p>
The role of this essay is to provide a brief speculation regarding the role
of the National Institute of Mental Health (NIMH) Research Domain Criteria (RDoC)
project in future psychiatric classification systems. Initiated by NIMH in 2009, RDoC
constitutes a framework for translational research that shifts the focus away from
traditional <italic>DSM/ICD</italic>
disorder categories and toward research on functional dimensions of
behavior or cognitive/affective processes (eg, reward learning or working memory) as
studied across the entire range of functioning from normal to abnormal. <sup><xref ref-type="bibr" rid="ref1">1</xref>-<xref ref-type="bibr" rid="ref3">3</xref></sup>
The paradigm emphasizes the inclusion in study designs of multiple
measures (eg, behavioral/cognitive, phenomenological, physiological) for examining such
psychological constructs, thus promoting an integrative rather than reductionistic
approach. <sup><xref ref-type="bibr" rid="ref4">4</xref></sup>
High priority is placed upon the examination of neurodevelopmental
processes and environmental influences (and their interaction) in research designs.
<sup><xref ref-type="bibr" rid="ref5">5</xref></sup>
<italic>Figure 1</italic>
depicts the way in which the various components of the RDoC framework are
organized to stimulate transdiagnostic research that can examine the joint influences of
biological and external risk factors. Neurodevelopment and environmental effects
represent important considerations in research designs, and various domains of function
(Negative Valence, etc) are studied across multiple Units of Analysis from Genes to
Self-Reports. (Both the Domains and Units of Analysis are considered as heuristic
exemplars rather than fixed components.)  </p>
<p>
A discussion of RDoC’s future role in classification necessarily depends
upon one’s long-term vision of what future nosologies might comprise and what assessment
problems they try to address. It is important to emphasize the phrase “long-term vision”
since the aim of current diagnostic manuals centers explicitly upon clinical utility
<sup><xref ref-type="bibr" rid="ref6">6</xref></sup>
; this seems to reflect a tacit assumption that current diagnoses and
treatments will change only modestly and incrementally over time, and that the
symptom-based architecture of disorder categories will remain static. In contrast, a
major role of funding agencies is to generate new concepts and research, pursuing
breakthroughs that could lead eventually to substantive reductions in the burden of
mental illness through enhanced treatment and prevention. As RDoC is a research
framework intended to inform future diagnostic systems, the long-term goal envisions a
precision- medicine concept that fosters empirically based approaches to
assessment, treatment, and prevention which can be updated rapidly on the basis of
ongoing data—much like current practices in other areas of medicine such as cancer.
<sup><xref ref-type="bibr" rid="ref7">7</xref></sup>
  </p>
<fig id="d38e137" orientation="portrait" position="float">
<label>Figure 1.</label>
<caption>
<title>Diagram of the RDoC Framework, illustrating the four major factors of
Neurodevelopment, Environment, Domains, and Units of Analysis (ranging from Genes
to Self-Reports).</title>
</caption>
<graphic xlink:href="DCNS_22.1_Cuthbert_figure1"></graphic>
</fig>
<p>
How can the RDoC framework contribute to this future vision? It is useful
to note that NIMH did not initiate the RDoC project as the pilot test for a new
classification system as such (much as the Research Diagnostic Criteria of the 1970s
represented a stalking horse for the <italic>DSM-III</italic>
). Rather, the initiative was a nascent idea that resulted from the
increasing realization that traditional disorders were broad and heterogeneous syndromes
that did not correspond to specific biological or behavioral systems and thus were
hampering efforts to develop new clinical tests or treatments <sup><xref ref-type="bibr" rid="ref8">8</xref></sup>
; the problem was compounded by a de facto practice in grant review
committees stipulating that clinical research should only be conducted in terms of
<italic>DSM/ICD</italic>
disorder categories. The RDoC alternative was to adopt a translational
approach: The framework consists of a set of flexible guidelines for approaching
psychopathology in terms of departures from normal-range functions rather than starting
with a priori disease definitions based upon sets of presenting symptoms.  </p>
</sec>
<sec>
<title>Key RDoC features </title>
<p>
This shift directly connects the accelerating body of basic research on
behavioral and neural functioning with psychopathology, enabling several novel
approaches. First, functional dimensions are explicitly conceived as psychophysiological
constructs that are jointly defined by data for a particular functional aspect of
behavior or cognition and data for an implementing neural circuit or system–thus
addressing head-on the mind-body challenges that have long stymied attempts to
understand biological aspects of mental disorders (and the attendant eliminative
reductionism that has proved controversial in so many quarters). Second, such a
perspective encourages the study of dysregulated functioning (eg, cognitive problems,
disrupted motivational processes), in addition to symptom reports, as significant
problems in and of themselves rather than as one of several indices of an “underlying”
syndrome.  </p>
<p>
Relatedly, enhanced assessment of behavioral/cognitive functions enables
the use of quantitative measurements that bring to bear modern psychometric and
computational techniques as opposed to qualitative symptom reports. <sup><xref ref-type="bibr" rid="ref9">9</xref></sup>
The functional domain approach also fosters the exploration of similar
mechanisms that are disrupted in multiple disorders (as implied by the extensive
comorbidity of current diagnostic classes), and the last decade has seen a notable
increase in various types of transdiagnostic studies that can help untangle questions
about whether or not similar kinds of impairment or symptoms across disorders can be
more efficiently regarded (and treated) as involving similar (or identical) mechanisms.
<sup><xref ref-type="bibr" rid="ref10">10</xref>,<xref ref-type="bibr" rid="ref11">11</xref></sup>
  </p>
<p>
An apt example is provided by a large program of anxiety disorders research
in which patients’ imagery of fearful and control situations were assessed with
psychophysiological measures. Five quintiles of patients were defined
transdiagnostically on the basis of highest-to-lowest psychophysiological reactivity
during aversive (as compared with neutral) images. Independent of primary diagnosis,
greater functional impairment and self-reported symptomatology were associated with
blunted physiological reactivity rather than the higher reactivity that might have been
expected. <sup><xref ref-type="bibr" rid="ref12">12</xref></sup>
These data demonstrate the utility of examining relationships among
multiple measures, and suggest the potential of physiological reactivity as a prognostic
biomarker for differential treatment (eg, exposure therapy versus medications or
cognitive therapy).  </p>
<p>
Finally, RDoC’s role as a flexible research framework serves as a model for
further major revisions to conceptions of mental illness–in the near term, in such
growing research areas as connectomics <sup><xref ref-type="bibr" rid="ref13">13</xref></sup>
and the genomics of functional systems <sup><xref ref-type="bibr" rid="ref14">14</xref></sup>
; and in the longer term, potentially radical change stemming from
computational modeling and machine learning. <sup><xref ref-type="bibr" rid="ref15">15</xref>,<xref ref-type="bibr" rid="ref16">16</xref></sup>
  </p>
</sec>
<sec>
<title>Early detection and prevention </title>
<p>
A more extended, but critically important, aspect of classification systems
in upcoming decades regards the capability for very early detection of future risk for
psychopathology. Such a consideration may not seem tethered to a classification system
at all with respect to current nosologies; however, a significant weakness of
symptom-based diagnostic systems is that, by definition, some pathological process is
already established by the time that a diagnosis can be made. The full-range dimensional
approach that RDoC embodies is well-positioned in order to reach toward future
prevention and pre-emption of disorders, in that growth patterns–whether assessed in
behavioral/cognitive, brain-based measures, or both–could be monitored across
neurodevelopment in order to detect early aberrations before any overt symptoms are
present. For instance, data from the Pennsylvania Neurodevelopmental Cohort have shown
that the onset of psychotic symptoms in adolescence is associated with relatively lower
cognitive test scores across development (compared with typically developing
participants) in an unselected sample of children. <sup><xref ref-type="bibr" rid="ref17">17</xref></sup>
These results imply that norms for cognitive and emotional growth across
childhood, similar to familiar height and weight charts for children, could be useful
tools in standard practice for early detection. At least one such effort is already
under way: A developmental battery that assesses six cognitive domains–employing
“gamified” tasks on a mobile e-platform to engage participants’ interest–has been
piloted for 3-year old children in rural India, with the goal of developing normative
curves across development as the project grows. <sup><xref ref-type="bibr" rid="ref18">18</xref></sup>
These projects demonstrate that quantitatively based efforts at
prevention, assessed relative to continuous population (or large-sample) distributions,
are not simply a promissory note but are already being implemented.  </p>
</sec>
<sec>
<title>Computational approaches </title>
<p>
Finally, the newly emerging field of computational psychiatry and the RDoC
framework have mutually influenced each other. <sup><xref ref-type="bibr" rid="ref19">19</xref></sup>
Given the indeterminate nature of traditional disorder categories, RDoC
has provided a more tractable basis for efforts to apply computational procedures to
psychopathology. Computational methods have been applied to two broad aspects of
research. The first aspect comprises computational modeling to validate model-based
predictions about relationships between brain activity and various aspects of behavior
in parametrically designed experiments, which typically involve functional operations
similar (often identical) to RDoC constructs. <sup><xref ref-type="bibr" rid="ref20">20</xref></sup>
The second aspect encompasses the use of computational techniques to
identify data-driven phenotypes not dependent upon traditional diagnoses, inspired in no
small part by the RDoC framework. <sup><xref ref-type="bibr" rid="ref21">21</xref>,<xref ref-type="bibr" rid="ref22">22</xref></sup>
This has proven to be a promising area for study: Although the subgenre is
only a few years old, several results suggesting actionable outcomes for treatment or
assessment have already appeared in the literature. <sup><xref ref-type="bibr" rid="ref23">23</xref>-<xref ref-type="bibr" rid="ref24">24</xref></sup>
For instance, a recent study employed a wide variety of measures to
analyze the heterogeneity in a large sample of patients diagnosed with schizophrenia,
schizoaffective disorder, or psychotic bipolar disorder; a multistep analysis revealed
three transdiagnostic clusters (“biotypes”) of patients defined primarily by cognitive
test scores and electrophysiological responses to various stimuli. Other measures
indicated that the biotypes comprised more biologically valid groupings than the
diagnostic categories, and the data suggested significant implications for more precise
clinical treatment. <sup><xref ref-type="bibr" rid="ref25">25</xref></sup>
Machine learning and artificial intelligence (AI) appear poised to produce
yet more generative findings, given the power of these techniques to find relationships
in high-dimensional data sets that integrate behavioral, symptomatic, and biological
measures. While such developments may seem far off, regulatory agencies are already
actively considering the process for approving use of AI and machine learning as medical
devices. <sup><xref ref-type="bibr" rid="ref26">26</xref></sup>
  </p>
</sec>
<sec>
<title>Conclusion </title>
<p>
In conclusion, the RDoC framework has catalyzed activities in multiple
areas of mental disorders research that can contribute to future classification systems
aligned with precision medicine avenues to diagnosis, treatment, and prevention. A
number of caveats are in order. First, a common criticism of RDoC from clinical
researchers and service providers holds that RDoC diverges too much from current
practice to be used by clinicians–a not unreasonable concern. However, there will
inevitably be a transition period as precision medicine procedures are introduced, and
the majority of current RDoC-themed research projects involve subgroups of one (or two)
current disorder categories. So, it is likely that service settings will experience
gradual shifts in assessment and treatment as new “biotypes” are validated and enter the
clinic. Second, some observers seem to infer that the introduction of biological and
quantified behavioral measures are threats to the use of traditional assessments and
individualized treatment plans. <sup><xref ref-type="bibr" rid="ref27">27</xref></sup>
However, individual assessments will remain essential for the vast
majority of patients, as life histories and symptom reports will be even more important
to precision medicine than current syndromal approaches. Finally, some researchers
regard the current RDoC framework as a finite set of components and constructs that are
insufficient to address the totality of mental illness. However, RDOC is better
understood as a set of dynamic principles with which the field can build a cumulating
knowledge base about psychopathology and how it emerges from perturbations in normal
functioning. Rapidly emerging data, technologies, and concepts consistent with the RDoC
approach demonstrate its capability to inform future versions of psychiatric
nosologies.  </p>
</sec>
</body>
<back>
<ack>
<p>The author reports no financial conflicts of interest</p>
</ack>
<ref-list>
<title>REFERENCES</title>
<ref id="ref1">
<label>1</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cuthbert</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Insel</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Toward the future of psychiatric diagnosis: The seven pillars of
RDoC</article-title>
<source/>
<italic>BMC Med</italic>
<year>2013</year>
<volume>11</volume>
<fpage>127</fpage>
<pub-id pub-id-type="pmid">23672587</pub-id>
</element-citation>
</ref>
<ref id="ref2">
<label>2</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morris</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Vaidyanathan</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Cuthbert</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Psychophysiological science and the Research Domain Criteria: A
commentary</article-title>
<source/>
<italic>Int J Psychophysiol</italic>
<year>2015</year>
<volume>98</volume>
<fpage>378</fpage>
<lpage>380</lpage>
<pub-id pub-id-type="pmid">26546860</pub-id>
</element-citation>
</ref>
<ref id="ref3">
<label>3</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sanislow</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Connecting psychopathology meta-structure and
mechanisms</article-title>
<source/>
<italic>J Abn Psychol</italic>
<year>2016</year>
<volume>125</volume>
<fpage>1158</fpage>
<lpage>1165</lpage>
</element-citation>
</ref>
<ref id="ref4">
<label>4</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kozak</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Cuthbert</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>The NIMH Research Domain Criteria initiative: Background, issues, and
pragmatics</article-title>
<source/>
<italic>Psychophysiology</italic>
<year>2016</year>
<volume>53</volume>
<fpage>286</fpage>
<lpage>297</lpage>
<pub-id pub-id-type="pmid">26877115</pub-id>
</element-citation>
</ref>
<ref id="ref5">
<label>5</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Casey</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Oliveri</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Insel</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>A neurodevelopmental perspective on the Research Domain Criteria
(RDoC) framework</article-title>
<source/>
<italic>Biol Psychiatry</italic>
<year>2014</year>
<volume>76</volume>
<fpage>350</fpage>
<lpage>353</lpage>
<pub-id pub-id-type="pmid">25103538</pub-id>
</element-citation>
</ref>
<ref id="ref6">
<label>6</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maj</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Why the clinical utility of diagnostic categories in psychiatry is
intrinsically limited and how we can use new approaches to complement
them</article-title>
<source/>
<italic>World Psychiatry</italic>
<year>2018</year>
<volume>17</volume>
<fpage>121</fpage>
<lpage>122</lpage>
<pub-id pub-id-type="pmid">29856539</pub-id>
</element-citation>
</ref>
<ref id="ref7">
<label>7</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fernandes</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Steiner</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Leboyer</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Carvalho</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Berk</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>The new field of ‘precision psychiatry’</article-title>
<source/>
<italic>BMC Med</italic>
<year>2017</year>
<volume>15</volume>
<fpage>80</fpage>
<pub-id pub-id-type="pmid">28403846</pub-id>
</element-citation>
</ref>
<ref id="ref8">
<label>8</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hyman</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Diagnosing the DSM: Diagnostic classification needs fundamental
reform</article-title>
<source/>
<italic>Cerebrum</italic>
<year>2011</year>
<fpage>6</fpage>
<pub-id pub-id-type="pmid">23447775</pub-id>
</element-citation>
</ref>
<ref id="ref9">
<label>9</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Markon</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Chmielewski</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>The reliability and validity of discrete and continuous measures of
psychopathology: A quantitative review</article-title>
<source/>
<italic>Psych Bull</italic>
<year>2011</year>
<volume>137</volume>
<fpage>856</fpage>
<lpage>879</lpage>
</element-citation>
</ref>
<ref id="ref10">
<label>10</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kas</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Penninx</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Sommer</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Serretti</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Arango</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Marston</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>A quantitative approach to neuropsychiatry: The why and the
how</article-title>
<source/>
<italic>Neurosci Biobehav Rev</italic>
<year>2019</year>
<volume>97</volume>
<fpage>3</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="pmid">29246661</pub-id>
</element-citation>
</ref>
<ref id="ref11">
<label>11</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kernbach</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Satterthwaite</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Bassett</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Smallwood</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Margulies</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Bzdok</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Shared endo- phenotypes of default mode dysfunction in
attention deficit/hyperactivity disorder and autism spectrum
disorder</article-title>
<source/>
<italic>Transl Psychiatry</italic>
<year>2018</year>
<volume>8</volume>
<fpage>133</fpage>
<pub-id pub-id-type="doi">10.1038/s41398-018-0179-6</pub-id>
<pub-id pub-id-type="pmid">30018328</pub-id>
</element-citation>
</ref>
<ref id="ref12">
<label>12</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lang</surname>
<given-names>P</given-names>
</name>
<name>
<surname>McTeague</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Bradley</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>RDoC, DSM, and the reflex physiology of fear: A biodimensional
analysis of the anxiety disorders spectrum</article-title>
<source/>
<italic>Psychophysiology</italic>
<year>2016</year>
<volume>53</volume>
<fpage>336</fpage>
<lpage>347</lpage>
<pub-id pub-id-type="pmid">26877123</pub-id>
</element-citation>
</ref>
<ref id="ref13">
<label>13</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smith</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Nichols</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Vidaurre</surname>
<given-names>D</given-names>
</name>
<name>
<surname>et al</surname>
<given-names></given-names>
</name>
</person-group>
<article-title>A positive-negative mode of population covariation links brain
connectivity, demographics, and behavior</article-title>
<source/>
<italic>Nat Neurosci</italic>
<year>2015</year>
<volume>18</volume>
<fpage>1565</fpage>
<lpage>1567</lpage>
<pub-id pub-id-type="pmid">26414616</pub-id>
</element-citation>
</ref>
<ref id="ref14">
<label>14</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bearden</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Glahn</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Cognitive genomics: Searching for the genetic roots of
neuropsychological functioning</article-title>
<source/>
<italic>Neuropsychol</italic>
<year>2017</year>
<volume>31</volume>
<fpage>1003</fpage>
<lpage>1019</lpage>
</element-citation>
</ref>
<ref id="ref15">
<label>15</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ferrante</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Redish</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Oquendo</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Averbeck</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Kinnane</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gordon</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Computational psychiatry: a report from the 2017 NIMH workshop on
opportunities and challenges</article-title>
<source/>
<italic>Mol Psychiatry</italic>
<year>2019</year>
<volume>24</volume>
<fpage>479</fpage>
<lpage>483</lpage>
<pub-id pub-id-type="pmid">29703948</pub-id>
</element-citation>
</ref>
<ref id="ref16">
<label>16</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Galatzer-Levy</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Ruggles</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Z</given-names>
</name>
</person-group>
<article-title>Data science in the Research Domain Criteria era: relevance of machine
learning to the study of stress pathology, recovery, and
resilience</article-title>
<source/>
<italic>Chronic Stress</italic>
<year>2018</year>
<volume>2</volume>
<fpage>1</fpage>
<lpage>14</lpage>
</element-citation>
</ref>
<ref id="ref17">
<label>17</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gur</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Calkins</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Satterthwaite</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Ruparel</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Bilker</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Moore</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Savitt</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hakonarson</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Gur</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Neurocognitive growth charting in psychosis spectrum
youths</article-title>
<source/>
<italic>JAMA Psychiatry</italic>
<year>2014</year>
<volume>71</volume>
<fpage>366</fpage>
<lpage>374</lpage>
<pub-id pub-id-type="pmid">24499990</pub-id>
</element-citation>
</ref>
<ref id="ref18">
<label>18</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bhavnani</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Mukherjee</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Dasgupta</surname>
<given-names>J</given-names>
</name>
<name>
<surname>et al</surname>
<given-names></given-names>
</name>
</person-group>
<article-title>Development, feasibility and acceptability of a gamified cognitive
developmental assessment on an E-Platform (DEEP) in rural Indian pre-schoolers – a
pilot study</article-title>
<source/>
<italic>Glob Health Action</italic>
<year>2019</year>
<volume>12</volume>
<fpage>1548005</fpage>
<pub-id pub-id-type="doi">10.080/16549716.2018.1548005</pub-id>
<pub-id pub-id-type="pmid">31154989</pub-id>
</element-citation>
</ref>
<ref id="ref19">
<label>19</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sanislow</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Ferrante</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Pacheco</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Rudorfer</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Morris</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Advancing translational research using NIMH Research Domain Criteria
and computational methods</article-title>
<source/>
<italic>Neuron</italic>
<year>2019</year>
<volume>101</volume>
<fpage>779</fpage>
<lpage>782</lpage>
<pub-id pub-id-type="pmid">30844398</pub-id>
</element-citation>
</ref>
<ref id="ref20">
<label>20</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Frank</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Redish</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Gordon</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Computational cognitive neuroscience approaches to deconstructing
mental function and dysfunction</article-title>
<source/>
Computational Psychiatry: New Perspectives on Mental Illness

          <year>2016</year>
<publisher-loc>Cambridge, MA</publisher-loc>
<publisher-name>MIT Press</publisher-name>
<fpage>101</fpage>
<lpage>120</lpage>
</element-citation>
</ref>
<ref id="ref21">
<label>21</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Adams</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Huys</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Roiser</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Computational psychiatry: towards a mathematically informed
understanding of mental illness</article-title>
<source/>
<italic>J Neurol Neurosurg Psychiatry</italic>
<year>2016</year>
<volume>87</volume>
<fpage>53</fpage>
<lpage>63</lpage>
<pub-id pub-id-type="pmid">26157034</pub-id>
</element-citation>
</ref>
<ref id="ref22">
<label>22</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stephan</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Bach</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Fletcher</surname>
<given-names>P</given-names>
</name>
<name>
<surname>et al</surname>
<given-names></given-names>
</name>
</person-group>
<article-title>Charting the landscape of priority problems in psychiatry, Part 1:
classification and diagnosis</article-title>
<source/>
<italic>Lancet Psychiatry</italic>
<year>2016</year>
<volume>3</volume>
<fpage>77</fpage>
<lpage>83</lpage>
<pub-id pub-id-type="pmid">26573970</pub-id>
</element-citation>
</ref>
<ref id="ref23">
<label>23</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Drysdale</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Grosenick</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Downar</surname>
<given-names>J</given-names>
</name>
<name>
<surname>et al</surname>
<given-names></given-names>
</name>
</person-group>
<article-title>Resting-state connectivity biomarkers define neurophysiological
subtypes of depression</article-title>
<source/>
<italic>Nat Med</italic>
<year>2017</year>
<volume>23</volume>
<fpage>28</fpage>
<lpage>38</lpage>
<pub-id pub-id-type="pmid">27918562</pub-id>
</element-citation>
</ref>
<ref id="ref24">
<label>24</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wolfers</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Doan</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Kaufmann</surname>
<given-names>T</given-names>
</name>
<name>
<surname>et al</surname>
<given-names></given-names>
</name>
</person-group>
<article-title>Mapping the heterogeneous phenotype of schizophrenia and bipolar
disorder using normative models</article-title>
<source/>
<italic>JAMA Psychiatry</italic>
<year>2018</year>
<volume>75</volume>
<fpage>1146</fpage>
<lpage>1155</lpage>
<pub-id pub-id-type="pmid">30304337</pub-id>
</element-citation>
</ref>
<ref id="ref25">
<label>25</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Clementz</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Sweeney</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hamm</surname>
<given-names>J</given-names>
</name>
<name>
<surname>et al</surname>
<given-names></given-names>
</name>
</person-group>
<article-title>Identification of distinct psychosis biotypes using grain-based
biomarkers</article-title>
<source/>
<italic>Am J Psychiatry</italic>
<year>2016</year>
<volume>173</volume>
<fpage>373</fpage>
<lpage>384</lpage>
<pub-id pub-id-type="pmid">26651391</pub-id>
</element-citation>
</ref>
<ref id="ref26">
<label>26</label>
<element-citation publication-type="book">
<collab>US Food and Drug Administration</collab>
<article-title>Proposed regulatory framework for modifications to artificial
intelligence/machine learning (AI-ML)-based software as a medical device
(SaMD)</article-title>
<date-in-citation>Accessed 31 Aug 2019</date-in-citation>
<publisher-name>U. S. Food and Drug Administration</publisher-name>
<comment>Available at: http://www.fda.gov/media/122535/download</comment>
</element-citation>
</ref>
<ref id="ref27">
<label>27</label>
<element-citation publication-type="book">
<article-title>June 2019: Advisory Report no. 9360</article-title>
<source/>
DSM(5): The use and status of diagnosis and classification of mental
health problems.

          <year>2019</year>
<month>6</month>
<publisher-loc>Brussels, Belgium</publisher-loc>
<publisher-name>Superior Health Council of Belgium</publisher-name>
<comment>Available at: https://www.health.belgium.be/sites/default/files/uploads/fields/fpshealth_theme_file/shc_9360_dsm5.pdf</comment>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>